Considering the benefits of CAR-NK over CAR-T, the accessibility of CD276-targeted CAR in prior investigations, and the distinctive CD276 expression on the human ESCC membrane, we initially generated iPSC CD276-targeted CAR-NK cells to evaluate their cytotoxicity against CD276-expressing ESCC. The gene discussed is CD276; the disease is esophageal squamous cell carcinoma.